39686609|t|Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years.
39686609|a|BACKGROUND: Changes in the Alzheimer's disease-related apolipoprotein genes expression, occurring parallel with brain ischemia-induced neurodegeneration in the hippocampal CA3 area, may be crucial for the development of memory loss and dementia. OBJECTIVE: The aim of the study was to investigate changes in genes expression of apolipoprotein A1 (APOA1), apolipoprotein E (APOE), and clusterin (CLU) in CA3 area post-ischemia with survival of 2 years. METHODS: The gene expression was evaluated with the use of an RT-PCR protocol after 2, 7, and 30 days and 6, 12, 18, and 24 months post-ischemia. RESULTS: The expression of the APOA1 gene (encoding apolipoprotein A1) was below the control values at 2 days, 6 and 12 months while at 7 and 30 days and 18 and 24 months post-ischemia this gene expression exceeded the control values. In the case of the CLU gene (encoding clusterin) expression, it was above the control values at all times post-ischemia. Similar expression was observed for the APOE gene (encoding apolipoprotein E) except on day 7 after ischemia where its expression was below the control value. CONCLUSIONS: The results seem to indicate that the observed changes in the gene expression may reflect the activation and inhibition of a variety of processes involved in ischemia-induced neurodegeneration. The enhanced expression of APOA1 and CLU genes may be associated with induction of neuroprotective mechanisms while increased expression of the APOE gene may produce detrimental effects.
39686609	16	21	APOA1	Gene	335
39686609	23	27	APOE	Gene	348
39686609	29	32	CLU	Gene	1191
39686609	94	102	ischemic	Disease	MESH:D002545
39686609	112	131	Alzheimer's disease	Disease	MESH:D000544
39686609	188	207	Alzheimer's disease	Disease	MESH:D000544
39686609	273	287	brain ischemia	Disease	MESH:D002545
39686609	296	313	neurodegeneration	Disease	MESH:D019636
39686609	381	392	memory loss	Disease	MESH:D008569
39686609	397	405	dementia	Disease	MESH:D003704
39686609	489	506	apolipoprotein A1	Gene	335
39686609	508	513	APOA1	Gene	335
39686609	516	532	apolipoprotein E	Gene	348
39686609	534	538	APOE	Gene	348
39686609	545	554	clusterin	Gene	1191
39686609	556	559	CLU	Gene	1191
39686609	578	586	ischemia	Disease	MESH:D007511
39686609	749	757	ischemia	Disease	MESH:D007511
39686609	790	795	APOA1	Gene	335
39686609	811	828	apolipoprotein A1	Gene	335
39686609	935	943	ischemia	Disease	MESH:D007511
39686609	1013	1016	CLU	Gene	1191
39686609	1032	1041	clusterin	Gene	1191
39686609	1105	1113	ischemia	Disease	MESH:D007511
39686609	1155	1159	APOE	Gene	348
39686609	1175	1191	apolipoprotein E	Gene	348
39686609	1215	1223	ischemia	Disease	MESH:D007511
39686609	1445	1453	ischemia	Disease	MESH:D007511
39686609	1462	1479	neurodegeneration	Disease	MESH:D019636
39686609	1508	1513	APOA1	Gene	335
39686609	1518	1521	CLU	Gene	1191
39686609	1625	1629	APOE	Gene	348
39686609	Association	MESH:D000544	348
39686609	Association	MESH:D007511	335
39686609	Association	MESH:D019636	348
39686609	Positive_Correlation	MESH:D007511	1191
39686609	Association	MESH:D007511	348
39686609	Association	MESH:D000544	335
39686609	Association	MESH:D000544	1191

